Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BackgroundThere is uncertainty about how much positive end-expiratory pressure (PEEP) should be used in patients with acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19).ObjectiveTo investigate whether a higher PEEP strategy is superior to a lower PEEP strategy regarding the number of ventilator-free days (VFDs).DesignMulticentre observational study conducted from 1 March to 1 June 2020.Setting and patientsTwenty-two ICUs in The Netherlands and 933 invasively ventilated COVID-19 ARDS patients.InterventionsPatients were categorised retrospectively as having received invasive ventilation with higher (n=259) or lower PEEP (n=674), based on the high and low PEEP/FiO2 tables of the ARDS Network, and using ventilator settings and parameters in the first hour of invasive ventilation, and every 8 h thereafter at fixed time points during the first four calendar days. We also used propensity score matching to control for observed confounding factors that might influence outcomes.Main outcomes and measuresThe primary outcome was the number of VFDs. Secondary outcomes included distant organ failures including acute kidney injury (AKI) and use of renal replacement therapy (RRT), and mortality.ResultsIn the unmatched cohort, the higher PEEP strategy had no association with the median [IQR] number of VFDs (2.0 [0.0 to 15.0] vs. 0.0 [0.0 to 16.0] days). The median (95% confidence interval) difference was 0.21 (-3.34 to 3.78) days, P = 0.905. In the matched cohort, the higher PEEP group had an association with a lower median number of VFDs (0.0 [0.0 to 14.0] vs. 6.0 [0.0 to 17.0] days) a median difference of -4.65 (-8.92 to -0.39) days, P = 0.032. The higher PEEP strategy had associations with higher incidence of AKI (in the matched cohort) and more use of RRT (in the unmatched and matched cohorts). The higher PEEP strategy had no association with mortality.ConclusionIn COVID-19 ARDS, use of higher PEEP may be associated with a lower number of VFDs, and may increase the incidence of AKI and need for RRT.Trial registrationPractice of VENTilation in COVID-19 is registered at ClinicalTrials.gov, NCT04346342.

Original publication

DOI

10.1097/eja.0000000000001565

Type

Journal article

Journal

European journal of anaesthesiology

Publication Date

12/2021

Volume

38

Pages

1274 - 1283

Addresses

From the Department of Intensive Care & Laboratory of Experimental Intensive Care and Anaesthesiology (LEICA), Amsterdam UMC, Location AMC, Amsterdam (CMAV, AMT, MB, LDJB, ASN, MJS, FP), Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands (JP), Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil (ASN), Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University (ASN), Data Analytics Research & Evaluation (DARE) Centre, Austin Hospital and University of Melbourne, Melbourne, Victoria, Australia (ASN), Nuffield Department of Medicine, Oxford University, Oxford, UK (MJS), Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand (MJS) and ACHIEVE Centre of Expertise, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, The Netherlands (FP).

Keywords

Writing Committee for the PRoVENT-COVID∗ Collaborative Group, Humans, Positive-Pressure Respiration, Retrospective Studies, Ventilators, Mechanical, Respiratory Distress Syndrome, COVID-19, SARS-CoV-2